BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Hou C, Wang H, Liu J, Xu Y, Cao Z, Gao Z. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24:422. [PMID: 32660650 DOI: 10.1186/s13054-020-03120-0] [Cited by in Crossref: 157] [Cited by in F6Publishing: 153] [Article Influence: 78.5] [Reference Citation Analysis]
Number Citing Articles
1 Azab SM, Zytoon AA, Kasemy ZAA, Omar SF, Ewida SF, Sakr KA, Ella TFA. Learning from pathophysiological aspects of COVID-19 clinical, laboratory, and high-resolution CT features: a retrospective analysis of 128 cases by disease severity. Emerg Radiol 2021;28:453-67. [PMID: 33417113 DOI: 10.1007/s10140-020-01875-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Florea RM, Sultana CM. COVID-19 and breastfeeding: can SARS-CoV-2 be spread through lactation? Discoveries (Craiova) 2021;9:e132. [PMID: 34754901 DOI: 10.15190/d.2021.11] [Reference Citation Analysis]
3 Biberoğlu S, İpekci A, İkizceli İ, Çakmak F, Akdeniz YS, Kanbakan A, Konukoğlu D, Bolayırlı İM, Börekçi Ş, Ürkmez S, Özkan S. Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19. Biomark Med 2021;15:1581-8. [PMID: 34704822 DOI: 10.2217/bmm-2021-0121] [Reference Citation Analysis]
4 Beeckmans S, Van Driessche E. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study. Front Mol Biosci 2021;8:671923. [PMID: 34109214 DOI: 10.3389/fmolb.2021.671923] [Reference Citation Analysis]
5 Manivannan M, Jogalekar MP, Kavitha MS, Maran BAV, Gangadaran P. A mini-review on the effects of COVID-19 on younger individuals. Exp Biol Med (Maywood) 2021;246:293-7. [PMID: 33210552 DOI: 10.1177/1535370220975118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
7 Tan AL, Farrow M, Biglands J, Fernandes RJ, Abraldes JA, de Souza Castro FA, de Souza HL, Arriel RA, Meireles A, Marocolo M, González-Rayas JM, Rayas-Gómez AL, Mobayed-Vega FN, González-Yáñez JM, Hirai DM, Belbis MD, Holmes MJ, Calvo N, Ferguson SK, Fernandes T, Oliveira EM, Pun M, Bhandari SS. Commentaries on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985) 2020;129:868-71. [PMID: 33027604 DOI: 10.1152/japplphysiol.00775.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhu J, Wei Z, Suryavanshi M, Chen X, Xia Q, Jiang J, Ayodele O, Bradbury BD, Brooks C, Brown CA, Cheng A, Critchlow CW, Devercelli G, Gandhi V, Gondek K, Londhe AA, Ma J, Jonsson-Funk M, Keenan HA, Manne S, Ren K, Sanders L, Yu P, Zhang J, Zhou L, Bao Y. Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study. BMJ Open 2021;11:e051588. [PMID: 34362806 DOI: 10.1136/bmjopen-2021-051588] [Reference Citation Analysis]
9 Gattinoni L, Marini JJ, Camporota L. The Respiratory Drive: An Overlooked Tile of COVID-19 Pathophysiology. Am J Respir Crit Care Med 2020;202:1079-80. [PMID: 32881583 DOI: 10.1164/rccm.202008-3142ED] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Yang J, Zhang P, Cheng WX, Lu Y, Gang W, Ren G. Exposing structural variations in SARS-CoV-2 evolution. Sci Rep 2021;11:22042. [PMID: 34764391 DOI: 10.1038/s41598-021-01650-3] [Reference Citation Analysis]
11 Al-Shuhaib MBS, Hashim HO, Al-Shuhaib JMB. Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study. Comput Biol Med 2021;141:105155. [PMID: 34942397 DOI: 10.1016/j.compbiomed.2021.105155] [Reference Citation Analysis]
12 Shirbhate E, Pandey J, Patel VK, Kamal M, Jawaid T, Gorain B, Kesharwani P, Rajak H. Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention. Pharmacol Rep 2021. [PMID: 34176080 DOI: 10.1007/s43440-021-00303-6] [Reference Citation Analysis]
13 Khanam R. Bidirectional Relationship between COVID-19 and Diabetes: Role of Renin-Angiotensin-Aldosterone System and Drugs Modulating It. J Pharm Bioallied Sci 2021;13:149-54. [PMID: 34349473 DOI: 10.4103/jpbs.JPBS_508_20] [Reference Citation Analysis]
14 Rizkita LD, Astuti I. The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review. J Pharm Anal 2021;11:265-71. [PMID: 33782640 DOI: 10.1016/j.jpha.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ghosh S, Mahalanobish S, Sil PC. Diabetes: discovery of insulin, genetic, epigenetic and viral infection mediated regulation. Nucleus (Calcutta) 2021;:1-15. [PMID: 34629548 DOI: 10.1007/s13237-021-00376-x] [Reference Citation Analysis]
16 Kamiya K, Komine M, Ohtsuki M. Biologics for Psoriasis during the COVID-19 Pandemic. J Clin Med 2021;10:1390. [PMID: 33808455 DOI: 10.3390/jcm10071390] [Reference Citation Analysis]
17 Matsoukas J, Apostolopoulos V, Zulli A, Moore G, Kelaidonis K, Moschovou K, Mavromoustakos T. From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy. Molecules 2021;26:618. [PMID: 33504092 DOI: 10.3390/molecules26030618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Carlström M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol 2021;17:575-90. [PMID: 34075241 DOI: 10.1038/s41581-021-00429-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Swain SS, Panda SK, Luyten W. Phytochemicals against SARS-CoV as potential drug leads. Biomed J 2021;44:74-85. [PMID: 33736953 DOI: 10.1016/j.bj.2020.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases 2021; 9(28): 8327-8339 [PMID: 34754842 DOI: 10.12998/wjcc.v9.i28.8327] [Reference Citation Analysis]
21 Singh L, Bajaj S, Gadewar M, Verma N, Ansari MN, Saeedan AS, Kaithwas G, Singh M. Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis. Front Immunol 2021;12:660632. [PMID: 34305892 DOI: 10.3389/fimmu.2021.660632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Habeichi NJ, Tannous C, Yabluchanskiy A, Altara R, Mericskay M, Booz GW, Zouein FA. Insights into the modulation of the interferon response and NAD+ in the context of COVID-19. Int Rev Immunol 2021;:1-11. [PMID: 34378474 DOI: 10.1080/08830185.2021.1961768] [Reference Citation Analysis]
23 Rajpoot S, Solanki K, Kumar A, Zhang KYJ, Pullamsetti SS, Savai R, Faisal SM, Pan Q, Baig MS. In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern. Int J Pept Res Ther 2022;28:28. [PMID: 34924897 DOI: 10.1007/s10989-021-10339-0] [Reference Citation Analysis]
24 Menez S, Parikh CR. Overview of acute kidney manifestations and management of patients with COVID-19. Am J Physiol Renal Physiol 2021;321:F403-10. [PMID: 34448642 DOI: 10.1152/ajprenal.00173.2021] [Reference Citation Analysis]
25 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Reference Citation Analysis]
26 Koureas M, Amoutzias GD, Vontas A, Kyritsi M, Pinaka O, Papakonstantinou A, Dadouli K, Hatzinikou M, Koutsolioutsou A, Mouchtouri VA, Speletas M, Tsiodras S, Hadjichristodoulou C. Wastewater monitoring as a supplementary surveillance tool for capturing SARS-COV-2 community spread. A case study in two Greek municipalities. Environ Res 2021;200:111749. [PMID: 34310965 DOI: 10.1016/j.envres.2021.111749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, Antoranz A, Arijs I, Boeckx B, Bosisio FM, Casaer M, Dauwe D, De Wever W, Dooms C, Dreesen E, Emmaneel A, Filtjens J, Gouwy M, Gunst J, Hermans G, Jansen S, Lagrou K, Liston A, Lorent N, Meersseman P, Mercier T, Neyts J, Odent J, Panovska D, Penttila PA, Pollet E, Proost P, Qian J, Quintelier K, Raes J, Rex S, Saeys Y, Sprooten J, Tejpar S, Testelmans D, Thevissen K, Van Buyten T, Vandenhaute J, Van Gassen S, Velásquez Pereira LC, Vos R, Weynand B, Wilmer A, Yserbyt J, Garg AD, Matthys P, Wouters C, Lambrechts D, Wauters E, Wauters J. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun 2021;12:4117. [PMID: 34226537 DOI: 10.1038/s41467-021-24360-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Espino-Y-Sosa S, Martinez-Portilla RJ, Torres-Torres J, Solis-Paredes JM, Estrada-Gutierrez G, Hernandez-Pacheco JA, Espejel-Nuñez A, Mateu-Rogell P, Juarez-Reyes A, Lopez-Ceh FE, Villafan-Bernal JR, Rojas-Zepeda L, Guzman-Guzman IP, Poon LC. Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19. Viruses 2021;13:1906. [PMID: 34696336 DOI: 10.3390/v13101906] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Flinn B, Royce N, Gress T, Chowdhury N, Santanam N. Dual role for angiotensin-converting enzyme 2 in Severe Acute Respiratory Syndrome Coronavirus 2 infection and cardiac fat. Obes Rev 2021;22:e13225. [PMID: 33660398 DOI: 10.1111/obr.13225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Dey D, Paul PK, Al Azad S, Al Mazid MF, Khan AM, Sharif MA, Rahman MH. Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing. J Adv Vet Anim Res 2021;8:24-35. [PMID: 33860009 DOI: 10.5455/javar.2021.h481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Deana C, Vetrugno L, Fabris M, Curcio F, Sozio E, Tascini C, Bassi F. Pericardial Cytokine "Storm" in a COVID-19 Patient: the Confirmation of a Hypothesis. Inflammation 2021. [PMID: 34533672 DOI: 10.1007/s10753-021-01563-3] [Reference Citation Analysis]
33 Satarker S, Tom AA, Shaji RA, Alosious A, Luvis M, Nampoothiri M. JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy. Postgrad Med 2021;133:489-507. [PMID: 33245005 DOI: 10.1080/00325481.2020.1855921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
34 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Reference Citation Analysis]
35 Dolatshahi M, Sabahi M, Aarabi MH. Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration. Mol Neurobiol 2021;58:2379-94. [PMID: 33417221 DOI: 10.1007/s12035-020-02236-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
36 Jin A, Zhao Y, Yuan Y, Ma S, Chen J, Yang X, Lu S, Sun Q. Single Treatment of Vitamin D3 Ameliorates LPS-Induced Acute Lung Injury through Changing Lung Rodentibacter abundance. Mol Nutr Food Res 2021;:e2100952. [PMID: 34894076 DOI: 10.1002/mnfr.202100952] [Reference Citation Analysis]
37 Nour S. Endothelial shear stress enhancements: a potential solution for critically ill Covid-19 patients. Biomed Eng Online 2020;19:91. [PMID: 33272285 DOI: 10.1186/s12938-020-00835-7] [Reference Citation Analysis]
38 Isaac-Lam MF. Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex. In Silico Pharmacol 2021;9:55. [PMID: 34631362 DOI: 10.1007/s40203-021-00114-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Morse J, Gay W, Korwek KM, McLean LE, Poland RE, Guy J, Sands K, Perlin JB. Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients. Endocrinol Diabetes Metab 2021;4:e00291. [PMID: 34505406 DOI: 10.1002/edm2.291] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Blumenthal JA, Duvall MG. Invasive and noninvasive ventilation strategies for acute respiratory failure in children with coronavirus disease 2019. Curr Opin Pediatr 2021;33:311-8. [PMID: 33851935 DOI: 10.1097/MOP.0000000000001021] [Reference Citation Analysis]
41 Geldsetzer P, Mukama T, Jawad N, Riffe T, Rogers A, Sudharsanan N. Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death. medRxiv 2021:2021. [PMID: 33655277 DOI: 10.1101/2021.02.23.21252314] [Reference Citation Analysis]
42 Alfano G, Fontana F, Mori G, Giaroni F, Ferrari A, Giovanella S, Ligabue G, Ascione E, Cazzato S, Ballestri M, Di Gaetano M, Meschiari M, Menozzi M, Milic J, Andrea B, Franceschini E, Cuomo G, Magistroni R, Mussini C, Cappelli G, Guaraldi G; Modena Covid-19 Working Group (MoCo19). Acid base disorders in patients with COVID-19. Int Urol Nephrol 2021. [PMID: 34115260 DOI: 10.1007/s11255-021-02855-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Baltaziak K, Szpringer A, Czarnek-Chudzik A, Onyszkiewicz M, Toro MD, Pankowska A, Pietura R, Rejdak R, Nowomiejska K. Quadrantanopia as the only symptom of post-COVID stroke in the occipital pole: Case report. Medicine (Baltimore) 2021;100:e27542. [PMID: 34871216 DOI: 10.1097/MD.0000000000027542] [Reference Citation Analysis]
44 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
45 Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, Gänzer H, von Bary C, May AE, Wöll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, Kääb S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von Stülpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med 2021;9:863-72. [PMID: 34126053 DOI: 10.1016/S2213-2600(21)00214-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Mba IE, Sharndama HC, Osondu-Chuka GO, Okeke OP. Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update. Infect Dis (Lond) 2021;53:559-80. [PMID: 33905282 DOI: 10.1080/23744235.2021.1916071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Jiang L, Yang Y, Gandhewar J. Bilateral corneal endothelial failure following COVID-19 pneumonia. BMJ Case Rep 2021;14:e242702. [PMID: 34544701 DOI: 10.1136/bcr-2021-242702] [Reference Citation Analysis]
48 Traboulsi H, Khedr MA, Al-Faiyz YSS, Elgorashe R, Negm A. Structure-Based Epitope Design: Toward a Greater Antibody-SARS-CoV-2 RBD Affinity. ACS Omega 2021;6:31469-76. [PMID: 34869973 DOI: 10.1021/acsomega.1c03348] [Reference Citation Analysis]
49 Sabetian S, Castiglioni I, Jahromi BN, Mousavi P, Cava C. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection. Cells 2021;10:1480. [PMID: 34204705 DOI: 10.3390/cells10061480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Chen J, Cheong C, Lan L, Zhou X, Liu J, Lyu A, Cheung WK, Zhang L. DeepDRIM: a deep neural network to reconstruct cell-type-specific gene regulatory network using single-cell RNA-seq data. Brief Bioinform 2021;22:bbab325. [PMID: 34424948 DOI: 10.1093/bib/bbab325] [Reference Citation Analysis]
51 Ozkan S, Cakmak F, Konukoglu D, Biberoglu S, Ipekci A, Akdeniz YS, Bolayirli IM, Balkan II, Dumanli GY, Ikizceli I. Efficacy of Serum Angiotensin II Levels in Prognosis of Patients With Coronavirus Disease 2019. Crit Care Med 2021;49:e613-23. [PMID: 33630767 DOI: 10.1097/CCM.0000000000004967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Watson A, Öberg L, Angermann B, Spalluto CM, Hühn M, Burke H, Cellura D, Freeman A, Muthas D, Etal D, Belfield G, Karlsson F, Nordström K, Ostridge K, Staples KJ, Wilkinson T; MICA II Studygroup. Dysregulation of COVID-19 related gene expression in the COPD lung. Respir Res 2021;22:164. [PMID: 34051791 DOI: 10.1186/s12931-021-01755-3] [Reference Citation Analysis]
53 P KM, Sivashanmugam K, Kandasamy M, Subbiah R, Ravikumar V. Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors. Life Sci 2021;266:118883. [PMID: 33316266 DOI: 10.1016/j.lfs.2020.118883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Bakadia BM, Boni BOO, Ahmed AAQ, Yang G. The impact of oxidative stress damage induced by the environmental stressors on COVID-19. Life Sci 2021;264:118653. [PMID: 33115606 DOI: 10.1016/j.lfs.2020.118653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
55 Bakakos A, Krompa A. Asthma in the era of SARS CoV-2 virus. J Asthma 2021;:1-8. [PMID: 34112029 DOI: 10.1080/02770903.2021.1941093] [Reference Citation Analysis]
56 Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol 2021;12:686029. [PMID: 34276671 DOI: 10.3389/fimmu.2021.686029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Vitiello A, Ferrara F. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients. Wien Klin Wochenschr 2021. [PMID: 33877436 DOI: 10.1007/s00508-021-01855-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
58 Kaur R, Singh S, Singh TG, Sood P, Robert J. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination. Inflammopharmacology 2022. [PMID: 34981320 DOI: 10.1007/s10787-021-00904-w] [Reference Citation Analysis]
59 Gowri A, Ashwin Kumar N, Suresh Anand BS. Recent advances in nanomaterials based biosensors for point of care (PoC) diagnosis of Covid-19 - A minireview. Trends Analyt Chem 2021;137:116205. [PMID: 33531721 DOI: 10.1016/j.trac.2021.116205] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
60 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
61 Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021;22:229-240. [PMID: 33054481 DOI: 10.1080/14656566.2020.1837114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Rex DAB, Dagamajalu S, Kandasamy RK, Raju R, Prasad TSK. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19. J Cell Commun Signal 2021. [PMID: 34181169 DOI: 10.1007/s12079-021-00632-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
63 Unuofin JO, Masuku NP, Paimo OK, Lebelo SL. Ginger from Farmyard to Town: Nutritional and Pharmacological Applications. Front Pharmacol 2021;12:779352. [PMID: 34899343 DOI: 10.3389/fphar.2021.779352] [Reference Citation Analysis]
64 Polese J, Sant'Ana L, Moulaz IR, Lara IC, Bernardi JM, Lima MD, Turini EAS, Silveira GC, Duarte S, Mill JG. Pulmonary function evaluation after hospital discharge of patients with severe COVID-19. Clinics (Sao Paulo) 2021;76:e2848. [PMID: 34190851 DOI: 10.6061/clinics/2021/e2848] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Nassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, Nyein A, Mohamed M, Alqassieh A, Soliman K, Alfishawy M, Sachmechi I, Misra A. Diabetes Mellitus and COVID-19: Review Article. Diabetes Metab Syndr 2021;15:102268. [PMID: 34562865 DOI: 10.1016/j.dsx.2021.102268] [Reference Citation Analysis]
66 Balkrishna A, Haldar S, Singh H, Roy P, Varshney A. Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction. J Inflamm Res 2021;14:869-84. [PMID: 33758527 DOI: 10.2147/JIR.S298242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
67 Yang J, Zhang P, Cheng WX, Lu Y, Gang W, Ren G. Exposing Structural Variations in SARS-CoV-2 Evolution. Res Sq 2021:rs. [PMID: 34545355 DOI: 10.21203/rs.3.rs-800496/v1] [Reference Citation Analysis]
68 Bayat M, Asemani Y, Najafi S. Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. Int Immunopharmacol 2021;97:107679. [PMID: 33930707 DOI: 10.1016/j.intimp.2021.107679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Law S, Lo C, Han J, Leung AW, Xu C. Photodynamic therapy with curcumin for combating SARS-CoV-2. Photodiagnosis Photodyn Ther 2021;34:102284. [PMID: 33836277 DOI: 10.1016/j.pdpdt.2021.102284] [Reference Citation Analysis]
70 Aykac K, Ozsurekci Y, Yayla BCC, Gurlevik SL, Oygar PD, Bolu NB, Tasar MA, Erdinc FS, Ertem GT, Neselioglu S, Erel O, Cengiz AB, Ceyhan M. Oxidant and antioxidant balance in patients with COVID-19. Pediatr Pulmonol 2021;56:2803-10. [PMID: 34265172 DOI: 10.1002/ppul.25549] [Reference Citation Analysis]
71 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Ramasamy S, Subbian S. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. Clin Microbiol Rev 2021;34:e00299-20. [PMID: 33980688 DOI: 10.1128/CMR.00299-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
73 Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Amin A, Vartanian A, Poladian N, Voloshko A, Yegiazaryan A, Al-Kassir AL, Venketaraman V. Root Causes of Fungal Coinfections in COVID-19 Infected Patients. Infect Dis Rep 2021;13:1018-35. [PMID: 34940403 DOI: 10.3390/idr13040093] [Reference Citation Analysis]
75 Zagidullin NS, Motloch LJ, Musin TI, Bagmanova ZA, Lakman IA, Tyurin AV, Gumerov RM, Enikeev D, Cai B, Gareeva DF, Davtyan PA, Gareev DA, Talipova HM, Badykov MR, Jirak P, Kopp K, Hoppe UC, Pistulli R, Pavlov VN. J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality? PLoS One 2021;16:e0257982. [PMID: 34648510 DOI: 10.1371/journal.pone.0257982] [Reference Citation Analysis]
76 Narożna M, Rubiś B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int J Mol Sci 2021;22:8663. [PMID: 34445368 DOI: 10.3390/ijms22168663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Li S, Cheng CS, Zhang C, Tang GY, Tan HY, Chen HY, Wang N, Lai AY, Feng Y. Edible and Herbal Plants for the Prevention and Management of COVID-19. Front Pharmacol 2021;12:656103. [PMID: 33995078 DOI: 10.3389/fphar.2021.656103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Ahmad MA, Mustafa F, Panicker N, Rizvi TA. Optical Detection of SARS-CoV-2 Utilizing Antigen-Antibody Binding Interactions. Sensors (Basel) 2021;21:6596. [PMID: 34640920 DOI: 10.3390/s21196596] [Reference Citation Analysis]
79 Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos JF, Kim NY, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Int J Nanomedicine 2021;16:539-60. [PMID: 33519200 DOI: 10.2147/IJN.S283686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 13.0] [Reference Citation Analysis]
80 Aldossary B, Hassan A, Moussa M, Alsaif HS, Alfaraj D. Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report. Int J Emerg Med 2021;14:24. [PMID: 33882839 DOI: 10.1186/s12245-021-00349-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int 2021;21:431. [PMID: 34399734 DOI: 10.1186/s12935-021-02129-x] [Reference Citation Analysis]
82 Nikiforuk AM, Kuchinski KS, Twa DDW, Lukac CD, Sbihi H, Basham CA, Steidl C, Prystajecky NA, Jassem AN, Krajden M, Patrick DM, Sekirov I. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada. EBioMedicine 2021;66:103316. [PMID: 33819740 DOI: 10.1016/j.ebiom.2021.103316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
83 Rath S, Perikala V, Jena AB, Dandapat J. Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs. Biomed Pharmacother 2021;143:112095. [PMID: 34479017 DOI: 10.1016/j.biopha.2021.112095] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Dewanjee S, Kandimalla R, Kalra RS, Valupadas C, Vallamkondu J, Kolli V, Dey Ray S, Reddy AP, Reddy PH. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges. Cells 2021;10:3291. [PMID: 34943795 DOI: 10.3390/cells10123291] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Yurttaser Ocak S, Ozturan SG, Bas E. Pupil responses in patients with COVID-19. Int Ophthalmol 2021. [PMID: 34613562 DOI: 10.1007/s10792-021-02053-z] [Reference Citation Analysis]
86 Hwang M, Wilson K, Wendt L, Pohlman J, Densmore E, Kaeppler C, Van Arendonk K, Yale S. The Great Gut Mimicker: A case report of MIS-C and appendicitis clinical presentation overlap in a teenage patient. BMC Pediatr 2021;21:258. [PMID: 34074244 DOI: 10.1186/s12887-021-02724-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Akhtar H, Khalid S, Ur Rahman F, Umar M, Ali S, Afridi M, Hassan F, Saleh Khader Y, Akhtar N, Mujeeb Khan M, Ikram A. Presenting characteristics, comorbidities, and outcomes among COVID-19 patients hospitalized in twin cities of Pakistan. JMIR Public Health Surveill 2021. [PMID: 34710053 DOI: 10.2196/32203] [Reference Citation Analysis]
88 Deligiorgi MV, Siasos G, Vakkas L, Trafalis DT. Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution. Cancers (Basel) 2021;13:5785. [PMID: 34830939 DOI: 10.3390/cancers13225785] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Kifle ZD, Woldeyohanis AE, Demeke CA. A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19. Metabol Open 2021;12:100137. [PMID: 34664036 DOI: 10.1016/j.metop.2021.100137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Brendler T, Al‐harrasi A, Bauer R, Gafner S, Hardy ML, Heinrich M, Hosseinzadeh H, Izzo AA, Michaelis M, Nassiri‐asl M, Panossian A, Wasser SP, Williamson EM. Botanical drugs and supplements affecting the immune response in the time of COVID ‐19: Implications for research and clinical practice. Phytotherapy Research 2021;35:3013-31. [DOI: 10.1002/ptr.7008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
91 Ramadan MS, Bertolino L, Marrazzo T, Florio MT, Durante-Mangoni E; The Monaldi Hospital Cardiovascular Infection Study Group. Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med 2021. [PMID: 34046852 DOI: 10.1007/s11739-021-02763-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Ramezanpour M, Bolt H, Hon K, Bouras GS, Psaltis AJ, Wormald PJ, Vreugde S. Cytokine-Induced Modulation of SARS-CoV2 Receptor Expression in Primary Human Nasal Epithelial Cells. Pathogens 2021;10:848. [PMID: 34357998 DOI: 10.3390/pathogens10070848] [Reference Citation Analysis]
93 Dahal A, Sonju JJ, Kousoulas KG, Jois SD. Peptides and peptidomimetics as therapeutic agents for Covid-19. Pept Sci (Hoboken) 2021;:e24245. [PMID: 34901700 DOI: 10.1002/pep2.24245] [Reference Citation Analysis]
94 Martínez-Botía P, Bernardo Á, Acebes-Huerta A, Caro A, Leoz B, Martínez-Carballeira D, Palomo-Antequera C, Soto I, Gutiérrez L. Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns. J Clin Med 2021;10:1073. [PMID: 33806709 DOI: 10.3390/jcm10051073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
95 Vergara J, Lirani-Silva C, Brodsky MB, Miles A, Clavé P, Nascimento W, Mourão LF. Potential Influence of Olfactory, Gustatory, and Pharyngolaryngeal Sensory Dysfunctions on Swallowing Physiology in COVID-19. Otolaryngol Head Neck Surg 2021;164:1134-5. [PMID: 33167752 DOI: 10.1177/0194599820972680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
96 Siddiqa MA, Rao DS, Suvarna G, Chennamachetty VK, Verma MK, Rao MVR. In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2. Int J Pept Res Ther 2021;:1-8. [PMID: 33746660 DOI: 10.1007/s10989-021-10196-x] [Reference Citation Analysis]
97 Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci 2020;10:148. [PMID: 33380340 DOI: 10.1186/s13578-020-00519-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
98 Sen R, Sengupta D, Mukherjee A. Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat. Environ Sci Pollut Res Int 2021. [PMID: 34859345 DOI: 10.1007/s11356-021-16356-2] [Reference Citation Analysis]
99 Gozman L, Perry K, Nikogosov D, Klabukov I, Shevlyakov A, Baranova A. A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients. Front Genet 2021;12:709388. [PMID: 34603376 DOI: 10.3389/fgene.2021.709388] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Huang R, Huestis M, Gan ES, Ooi EE, Ohh M. Hypoxia and viral infectious diseases. JCI Insight 2021;6:147190. [PMID: 33830079 DOI: 10.1172/jci.insight.147190] [Reference Citation Analysis]
101 Todorov P, Georgieva S, Staneva D, Peneva P, Grozdanov P, Nikolova I, Grabchev I. Synthesis of New Modified with Rhodamine B Peptides for Antiviral Protection of Textile Materials. Molecules 2021;26:6608. [PMID: 34771015 DOI: 10.3390/molecules26216608] [Reference Citation Analysis]
102 Kate Gadanec L, Qaradakhi T, Renee McSweeney K, Ashiana Ali B, Zulli A, Apostolopoulos V. Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment. Future Microbiol 2021;16:205-9. [PMID: 33569984 DOI: 10.2217/fmb-2021-0018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Mastitskaya S, Thompson N, Holder D. Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease. Front Neurosci 2021;15:667036. [PMID: 33927594 DOI: 10.3389/fnins.2021.667036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
104 Santacroce L, Inchingolo F, Topi S, Del Prete R, Di Cosola M, Charitos IA, Montagnani M. Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective. Diabetes Metab Syndr 2021;15:295-301. [PMID: 33484986 DOI: 10.1016/j.dsx.2020.12.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
105 Capriotti V, Mattioli F, Guida F, Marcuzzo AV, Lo Manto A, Martone A, Molinari G, Fabbris C, Menegaldo A, Calvanese L, Latini G, Cingolani C, Gradoni P, Boscolo Nata F, De Sisti C, Selle V, Leone G, Indelicato P, Pilolli F, Mevio N, Roncoroni L, Papi S, Meschiari M, Tominz R, D'Ascanio L, Dragonetti A, Torelli L, Trenti L, Spinato G, Boscolo-Rizzo P, Bussi M, Cossarizza A, Presutti L, Tirelli G. COVID-19 in the tonsillectomised population. Acta Otorhinolaryngol Ital 2021;41:197-205. [PMID: 33970896 DOI: 10.14639/0392-100X-N1436] [Reference Citation Analysis]
106 Quarleri J, Cevallos C, Delpino MV. Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection. Immunol Lett 2021;232:35-8. [PMID: 33581170 DOI: 10.1016/j.imlet.2021.02.002] [Reference Citation Analysis]
107 Serra A, Fratello M, Federico A, Ojha R, Provenzani R, Tasnadi E, Cattelani L, Del Giudice G, Kinaret PAS, Saarimäki LA, Pavel A, Kuivanen S, Cerullo V, Vapalahti O, Horvath P, Lieto AD, Yli-Kauhaluoma J, Balistreri G, Greco D. Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation. Brief Bioinform 2021:bbab507. [PMID: 34962256 DOI: 10.1093/bib/bbab507] [Reference Citation Analysis]
108 Hazeldine J, Lord JM. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets. Front Immunol 2021;12:680134. [PMID: 34149717 DOI: 10.3389/fimmu.2021.680134] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
109 Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, Smith AD. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19.Nutrients. 2020;12:3760. [PMID: 33297491 DOI: 10.3390/nu12123760] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
110 Basu A, Pamreddy A, Singh P, Sharma K. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. J Mol Biol 2021;:167213. [PMID: 34437890 DOI: 10.1016/j.jmb.2021.167213] [Reference Citation Analysis]
111 Ginsburg I, Fibach E. Polycations and polyanions in SARS-CoV-2 infection. Med Hypotheses 2021;146:110470. [PMID: 33412501 DOI: 10.1016/j.mehy.2020.110470] [Reference Citation Analysis]
112 Satsangi S, Gupta N, Kodan P. Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver. J Clin Transl Hepatol 2021;9:436-46. [PMID: 34221930 DOI: 10.14218/JCTH.2020.00174] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Samidoust P, Esmaeili Delshad MS, Navid Talemi R, Mojtahedi K, Samidoust A, Jahangiri S, Ashoobi MT. Incidence, characteristics, and outcome of COVID-19 in patients on liver transplant program: a retrospective study in the north of Iran. New Microbes New Infect 2021;44:100935. [PMID: 34493955 DOI: 10.1016/j.nmni.2021.100935] [Reference Citation Analysis]
114 Samuel SM, Varghese E, Büsselberg D. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role. Trends Microbiol 2021:S0966-842X(21)00063-9. [PMID: 33785249 DOI: 10.1016/j.tim.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
115 Akbari M, Taheri M, Mehrpoor G, Eslami S, Hussen BM, Ghafouri-Fard S, Arefian N. Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients. Vascul Pharmacol 2021;142:106934. [PMID: 34774774 DOI: 10.1016/j.vph.2021.106934] [Reference Citation Analysis]
116 Saed Aldien A, Ganesan GS, Wahbeh F, Al-Nassr N, Altarawneh H, Al Theyab L, Saed Aldien S, Tomerak S, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation may induce cardiac injury in COVID-19 patients including children and adolescents without underlying cardiovascular diseases: A systematic review. Cardiovasc Revasc Med 2021:S1553-8389(21)00195-0. [PMID: 33952432 DOI: 10.1016/j.carrev.2021.04.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Zhang J, Huang X, Ding D, Zhang J, Xu L, Hu Z, Xu W, Tao Z. Comparative Study of Acute Lung Injury in COVID-19 and Non-COVID-19 Patients. Front Med (Lausanne) 2021;8:666629. [PMID: 34485324 DOI: 10.3389/fmed.2021.666629] [Reference Citation Analysis]
118 Khodabakhsh P, Asgari Taei A, Mohseni M, Bahrami Zanjanbar D, Khalili H, Masoumi K, Haji Abbas Shirazi A, Dargahi L. Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets. Arch Med Res 2021:S0188-4409(21)00122-3. [PMID: 34134920 DOI: 10.1016/j.arcmed.2021.05.007] [Reference Citation Analysis]
119 Yawar B, Marzouk A, Ali H, Asim A, Ghorab T, Bahli Z, Abousamra M, Fleville S. Acute Pancreatitis During COVID-19 Pandemic: An Overview of Patient Demographics, Disease Severity, Management and Outcomes in an Acute District Hospital in Northern Ireland. Cureus 2021;13:e18520. [PMID: 34659920 DOI: 10.7759/cureus.18520] [Reference Citation Analysis]
120 Pitre T, Dong AHT, Jones A, Kapralik J, Cui S, Mah J, Helmeczi W, Su J, Patel V, Zia Z, Mallender M, Tang X, Webb C, Patro N, Junek M, Duong M, Ho T, Beauchamp MK, Costa AP, Kruisselbrink R, Tsang JLY, Walsh M. Incidence and Outcomes of Acute Kidney Injury in Patients Admitted to Hospital With COVID-19: A Retrospective Cohort Study. Can J Kidney Health Dis 2021;8:20543581211027759. [PMID: 34290876 DOI: 10.1177/20543581211027759] [Reference Citation Analysis]
121 Olsen M, Lohning A, Campos M, Jones P, McKirdy S, Alghafri R, Tajouri L. Mobile phones of paediatric hospital staff are never cleaned and commonly used in toilets with implications for healthcare nosocomial diseases. Sci Rep 2021;11:12999. [PMID: 34155278 DOI: 10.1038/s41598-021-92360-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
122 Almutairi MM, Sivandzade F, Albekairi TH, Alqahtani F, Cucullo L. Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Front Med (Lausanne) 2021;8:745789. [PMID: 34901061 DOI: 10.3389/fmed.2021.745789] [Reference Citation Analysis]
123 Chandra S, Rawal R. The surge in Covid related mucormycosis. J Infect 2021;83:381-412. [PMID: 34126158 DOI: 10.1016/j.jinf.2021.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
124 Garg SS, Sharma A, Gupta J. Immunomodulation and immunotherapeutics of COVID-19. Clin Immunol 2021;231:108842. [PMID: 34461289 DOI: 10.1016/j.clim.2021.108842] [Reference Citation Analysis]
125 Kumar M, Joshi M, Patel AK, Joshi CG. Unravelling the early warning capability of wastewater surveillance for COVID-19: A temporal study on SARS-CoV-2 RNA detection and need for the escalation. Environ Res 2021;196:110946. [PMID: 33662347 DOI: 10.1016/j.envres.2021.110946] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
126 Nurullayev E, Gördü B, Özsürekçi Y, Haliloglu M, Soyer T. Acute appendicitis during the clinical course of COVID-19 in a 13-year-old boy: Complication or coincidental? Surg Pract 2021. [PMID: 34899958 DOI: 10.1111/1744-1633.12526] [Reference Citation Analysis]
127 Couvineau A, Gomariz RP, Tan YV. Editorial: GPCR in Inflammatory and Cancer Diseases. Front Endocrinol (Lausanne) 2020;11:588157. [PMID: 33101216 DOI: 10.3389/fendo.2020.588157] [Reference Citation Analysis]
128 Yapasert R, Khaw-On P, Banjerdpongchai R. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets. Molecules 2021;26:7459. [PMID: 34946543 DOI: 10.3390/molecules26247459] [Reference Citation Analysis]
129 Fröhlich E. Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics. Biomedicines 2021;9:1732. [PMID: 34829961 DOI: 10.3390/biomedicines9111732] [Reference Citation Analysis]
130 Sahu S, Patil CR, Kumar S, Apparsundaram S, Goyal RK. Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation. Mol Cell Biochem 2021. [PMID: 34655418 DOI: 10.1007/s11010-021-04275-2] [Reference Citation Analysis]
131 Rasaeifar B, Gomez-Gutierrez P, Perez JJ. Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors. Pharmaceuticals (Basel) 2020;13:E259. [PMID: 32967280 DOI: 10.3390/ph13090259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
132 Oh TK, Song IA. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study. BMC Pulm Med 2021;21:12. [PMID: 33407347 DOI: 10.1186/s12890-020-01387-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
133 Hu Y, Yang H, Hou C, Chen W, Zhang H, Ying Z, Hu Y, Sun Y, Qu Y, Feychting M, Valdimarsdottir U, Song H, Fang F. COVID-19 related outcomes among individuals with neurodegenerative diseases: a cohort analysis in the UK biobank. BMC Neurol 2022;22:15. [PMID: 34996388 DOI: 10.1186/s12883-021-02536-7] [Reference Citation Analysis]
134 Balkrishna A, Pokhrel S, Singh H, Joshi M, Mulay VP, Haldar S, Varshney A. Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model. Drug Des Devel Ther 2021;15:1111-33. [PMID: 33737804 DOI: 10.2147/DDDT.S292805] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
135 Saalabian K, Rolle U, Friedmacher F. Impact of the Global COVID-19 Pandemic on the Incidence, Presentation, and Management of Pediatric Appendicitis: Lessons Learned from the First Wave. Eur J Pediatr Surg 2021;31:311-8. [PMID: 34161983 DOI: 10.1055/s-0041-1731295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Feyaerts D, Hedou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E, Dhondalay GKR, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM, Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudilliere DK, Mukherjee N, Tsai AS, Rumer KK, Jiang SJ, Valdes-Ferrer SI, Kelly JD, Furman D, Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudilliere B, McIlwain DR. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. bioRxiv 2021:2021. [PMID: 33594362 DOI: 10.1101/2021.02.09.430269] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Cuevas-Gonzalez MV, Garcia-Perez Á, Gonzalez-Aragon Pineda ÁE, Espinosa-Cristobal LF, Donohue-Cornejo A, Tovar-Carrillo KL, Saucedo-Acuña RA, Cuevas-Gonzalez JC. Stem Cells as a Model of Study of SARS-CoV-2 and COVID-19: A Systematic Review of the Literature. Biomed Res Int 2021;2021:9915927. [PMID: 34458372 DOI: 10.1155/2021/9915927] [Reference Citation Analysis]
138 Dholariya S, Parchwani DN, Singh R, Sonagra A, Motiani A, Patel D. Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance. Indian J Clin Biochem 2021;:1-8. [PMID: 34219999 DOI: 10.1007/s12291-021-00991-0] [Reference Citation Analysis]
139 Attia YA, El-Saadony MT, Swelum AA, Qattan SYA, Al-Qurashi AD, Asiry KA, Shafi ME, Elbestawy AR, Gado AR, Khafaga AF, Hussein EOS, Ba-Awadh H, Tiwari R, Dhama K, Alhussaini B, Alyileili SR, El-Tarabily KA, Abd El-Hack ME. COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review. Environ Sci Pollut Res Int 2021;28:22241-64. [PMID: 33733422 DOI: 10.1007/s11356-021-13018-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
140 Guaman-Bautista LP, Moreta-Urbano E, Oña-Arias CG, Torres-Arias M, Kyriakidis NC, Malcı K, Jonguitud-Borrego N, Rios-Solis L, Ramos-Martinez E, López-Cortés A, Barba-Ostria C. Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies. Diagnostics (Basel) 2021;11:1981. [PMID: 34829328 DOI: 10.3390/diagnostics11111981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Singh B, Singh D, Verma V, Yadav R, Kumar R. Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review. J Pharm Anal 2021. [PMID: 34934510 DOI: 10.1016/j.jpha.2021.12.003] [Reference Citation Analysis]
142 Ahmadi M, Pashangzadeh S, Mousavi P, Saffarzadeh N, Amin Habibi M, Hajiesmaeili F, Rezaei N. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19. Int Immunopharmacol 2021;95:107568. [PMID: 33765612 DOI: 10.1016/j.intimp.2021.107568] [Reference Citation Analysis]
143 Lakhera S, Devlal K, Ghosh A, Chowdhury P, Rana M. Modelling the DFT structural and reactivity study of feverfew and evaluation of its potential antiviral activity against COVID-19 using molecular docking and MD simulations. Chem Pap . [DOI: 10.1007/s11696-022-02067-6] [Reference Citation Analysis]
144 Dwivedi R, Samanta P, Sharma P, Zhang F, Mishra SK, Kucheryavy P, Kim SB, Aderibigbe AO, Linhardt RJ, Tandon R, Doerksen RJ, Pomin VH. Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection. J Biol Chem 2021;297:101207. [PMID: 34537241 DOI: 10.1016/j.jbc.2021.101207] [Reference Citation Analysis]
145 Turana Y, Nathaniel M, Shen R, Ali S, Aparasu RR. Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications. Brain Sciences 2022;12:59. [DOI: 10.3390/brainsci12010059] [Reference Citation Analysis]
146 Vartak R, Patil SM, Saraswat A, Patki M, Kunda NK, Patel K. Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro. Nanomedicine (Lond) 2021;16:1187-202. [PMID: 33982600 DOI: 10.2217/nnm-2020-0475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
147 Alakeel YS, Alharbi EF, Alhaidal HA, Jumaa AM, Albaiahy LK, Alsagami NS, Alshahrani SA. The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients. J Infect Public Health 2022;15:56-64. [PMID: 34922224 DOI: 10.1016/j.jiph.2021.12.003] [Reference Citation Analysis]
148 Murch SH. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14. Med Hypotheses 2020;144:110168. [PMID: 33254494 DOI: 10.1016/j.mehy.2020.110168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
149 Vahedian-Azimi A, Keramatfar A, Asiaee M, Atashi SS, Nourbakhsh M. Do you have COVID-19? An artificial intelligence-based screening tool for COVID-19 using acoustic parameters. J Acoust Soc Am 2021;150:1945. [PMID: 34598596 DOI: 10.1121/10.0006104] [Reference Citation Analysis]
150 Saeed M, Saeed A, Alam MJ, Alreshidi M. Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach. Molecules 2020;25:E5657. [PMID: 33271751 DOI: 10.3390/molecules25235657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
151 Wu Y, Cheng X, Jiang G, Tang H, Ming S, Tang L, Lu J, Guo C, Shan H, Huang X. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes 2021;7:61. [PMID: 34294722 DOI: 10.1038/s41522-021-00232-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
152 Akhtar Z, Gallagher MM, Yap YG, Leung LWM, Elbatran AI, Madden B, Ewasiuk V, Gregory L, Breathnach A, Chen Z, Fluck DS, Sharma S. Prolonged QT predicts prognosis in COVID-19. Pacing Clin Electrophysiol 2021;44:875-82. [PMID: 33792080 DOI: 10.1111/pace.14232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
153 Gómez-Zorita S, Milton-Laskibar I, García-Arellano L, González M, Portillo MP. An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity. Int J Mol Sci 2021;22:7975. [PMID: 34360741 DOI: 10.3390/ijms22157975] [Reference Citation Analysis]
154 Tran S, Kuruppu S, Rajapakse NW. Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia? J Alzheimers Dis 2021. [PMID: 34897090 DOI: 10.3233/JAD-215231] [Reference Citation Analysis]
155 Soltani Hekmat A, Javanmardi K. Alamandine: Potential Protective Effects in SARS-CoV-2 Patients. J Renin Angiotensin Aldosterone Syst 2021;2021:6824259. [PMID: 34853605 DOI: 10.1155/2021/6824259] [Reference Citation Analysis]
156 Munavalli GG, Guthridge R, Knutsen-Larson S, Brodsky A, Matthew E, Landau M. "COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment". Arch Dermatol Res 2021. [PMID: 33559733 DOI: 10.1007/s00403-021-02190-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
157 Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, Yablonskiy P, Shoenfeld Y. Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form. Pathogens 2021;10:1408. [PMID: 34832564 DOI: 10.3390/pathogens10111408] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Reference Citation Analysis]
159 Law S, Leung AW, Xu C. Could nanotechnology assist traditional Chinese medicine (TCM) in photodynamic therapy (PDT) against SARS-CoV-2? Photodiagnosis Photodyn Ther 2021;36:102543. [PMID: 34547469 DOI: 10.1016/j.pdpdt.2021.102543] [Reference Citation Analysis]
160 Al-Ardhi FM, Novotny L, Alhunayan A, Al-Tannak NF. Comparison of remdesivir and favipiravir - the anti-Covid-19 agents mimicking purine RNA constituents. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34782799 DOI: 10.5507/bp.2021.063] [Reference Citation Analysis]
161 Lishman J, Kohler C, de Vos C, van der Zalm MM, Itana J, Redfern A, Smit L, Rabie H. Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19. Pediatric Infectious Disease Journal 2020;39:e472-3. [DOI: 10.1097/inf.0000000000002900] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 12.5] [Reference Citation Analysis]
162 da Rocha AP, Atallah AN, Aldrighi JM, Pires ALR, Dos Santos Puga ME, Pinto ACPN. Insufficient evidence for vitamin D use in COVID-19: A rapid systematic review. Int J Clin Pract 2021;:e14649. [PMID: 34310814 DOI: 10.1111/ijcp.14649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
163 Barciszewska AM. Elucidating of oxidative distress in COVID-19 and methods of its prevention. Chem Biol Interact 2021;344:109501. [PMID: 33974898 DOI: 10.1016/j.cbi.2021.109501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Chilosi M, Poletti V, Ravaglia C, Rossi G, Dubini A, Piciucchi S, Pedica F, Bronte V, Pizzolo G, Martignoni G, Doglioni C. The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime. Mod Pathol 2021;34:1444-55. [PMID: 33883694 DOI: 10.1038/s41379-021-00808-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
165 Elshaarawy O, Lashen SA, Makhlouf NA, Abdeltawab D, Zaghloul MS, Ahmed RM, Fathy H, Afifi S, Abdel-Gawad M, Abdelsameea E, Abd-Elsalam S, Mohamed SY, Tag-Adeen M, Tharwat M, Alzamzamy A, Bekhit AN, Eid AM, Awad A, Aamr M, Abd El Dayem WA, Wifi MN, Alboraie M. Barriers for resuming endoscopy service in the context of COVID-19 pandemic: A multicenter survey from Egypt. World J Gastroenterol 2020; 26(43): 6880-6890 [PMID: 33268968 DOI: 10.3748/wjg.v26.i43.6880] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Zhao L, Zhong K, Zhao J, Yong X, Tong A, Jia D. SARS-CoV-2 spike protein harnesses SNX27-mediated endocytic recycling pathway. MedComm (2020) 2021. [PMID: 34909756 DOI: 10.1002/mco2.92] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Kaye AD, Cornett EM, Brondeel KC, Lerner ZI, Knight HE, Erwin A, Charipova K, Gress KL, Urits I, Urman RD, Fox CJ, Kevil CG. Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment. Best Pract Res Clin Anaesthesiol 2021;35:269-92. [PMID: 34511219 DOI: 10.1016/j.bpa.2020.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Zaman MS, Sizemore RC. Diverse Manifestations of COVID-19: Some Suggested Mechanisms. Int J Environ Res Public Health 2021;18:9785. [PMID: 34574709 DOI: 10.3390/ijerph18189785] [Reference Citation Analysis]
169 Wijeratne T, Gillard Crewther S, Sales C, Karimi L. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review. Front Neurol 2020;11:607221. [PMID: 33584506 DOI: 10.3389/fneur.2020.607221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
170 Elkarow MH, Hamdy A. A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic. Front Endocrinol (Lausanne) 2020;11:569633. [PMID: 33240216 DOI: 10.3389/fendo.2020.569633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
171 Mehmood A, Khan S, Khan S, Ahmed S, Ali A, Xue M, Ali L, Hamza M, Munir A, Ur Rehman S, Mehmood Khan A, Hussain Shah A, Bai Q. In silico analysis of quranic and prophetic medicinals plants for the treatment of infectious viral diseases including corona virus. Saudi J Biol Sci 2021;28:3137-51. [PMID: 33642896 DOI: 10.1016/j.sjbs.2021.02.058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Jin B, Singh R, Ha SE, Zogg H, Park PJ, Ro S. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol 2021; 27(19): 2341-2352 [PMID: 34040326 DOI: 10.3748/wjg.v27.i19.2341] [Reference Citation Analysis]
173 Ferrandi PJ, Alway SE, Mohamed JS. Last Word on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985) 2020;129:872. [PMID: 33027605 DOI: 10.1152/japplphysiol.00785.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Latil M, Camelo S, Veillet S, Lafont R, Dilda PJ. Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients. Drug Discov Today 2021;26:1311-8. [PMID: 33609783 DOI: 10.1016/j.drudis.2021.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
175 Dessie G, Malik T. Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options. Infect Drug Resist 2021;14:1883-92. [PMID: 34079299 DOI: 10.2147/IDR.S308176] [Reference Citation Analysis]
176 Mahmoud IS, Jarrar YB. Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges. Mol Biol Rep 2021;48:4667-75. [PMID: 34023987 DOI: 10.1007/s11033-021-06390-1] [Reference Citation Analysis]
177 Sharma P, Sharma R. IMPACT OF COVID-19 ON MENTAL HEALTH AND AGING. Saudi J Biol Sci 2021. [PMID: 34377058 DOI: 10.1016/j.sjbs.2021.07.087] [Reference Citation Analysis]
178 DeOre BJ, Tran KA, Andrews AM, Ramirez SH, Galie PA. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation. J Neuroimmune Pharmacol 2021. [PMID: 34687399 DOI: 10.1007/s11481-021-10029-0] [Reference Citation Analysis]
179 Kaye AD, Spence AL, Mayerle M, Sardana N, Clay CM, Eng MR, Luedi MM, Carroll Turpin MA, Urman RD, Cornett EM. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes. Best Pract Res Clin Anaesthesiol 2021;35:437-48. [PMID: 34511231 DOI: 10.1016/j.bpa.2021.02.003] [Reference Citation Analysis]
180 Sharma A, Chakraborty A, Jaganathan BG. Review of the potential of mesenchymal stem cells for the treatment of infectious diseases. World J Stem Cells 2021; 13(6): 568-593 [PMID: 34249228 DOI: 10.4252/wjsc.v13.i6.568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Daei Sorkhabi A, Sarkesh A, Daei Sorkhabi A, Entezari-Maleki T, Rashedi J, Bannazadeh Baghi H. Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility. J Basic Clin Physiol Pharmacol 2021. [PMID: 34380185 DOI: 10.1515/jbcpp-2021-0111] [Reference Citation Analysis]
182 Faisal HMN, Katti KS, Katti DR. Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness. Chem Phys 2021;551:111353. [PMID: 34511698 DOI: 10.1016/j.chemphys.2021.111353] [Reference Citation Analysis]
183 Malkova A, Kudlay D, Kudryavtsev I, Starshinova A, Yablonskiy P, Shoenfeld Y. Immunogenetic Predictors of Severe COVID-19. Vaccines (Basel) 2021;9:211. [PMID: 33802310 DOI: 10.3390/vaccines9030211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
184 Damara FA, Muchamad GR, Ikhsani R, Hendro, Syafiyah AH, Bashari MH. Thyroid disease and hypothyroidism are associated with poor COVID-19 outcomes: A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2021;15:102312. [PMID: 34731819 DOI: 10.1016/j.dsx.2021.102312] [Reference Citation Analysis]
185 Aljohmani A, Yildiz D. A Disintegrin and Metalloproteinase-Control Elements in Infectious Diseases. Front Cardiovasc Med 2020;7:608281. [PMID: 33392273 DOI: 10.3389/fcvm.2020.608281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
186 Traboulsi H, Khedr MA, Elgorashe R, Al-Faiyz Y, Negm A. Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes. Arab J Chem 2021;:103631. [PMID: 34909055 DOI: 10.1016/j.arabjc.2021.103631] [Reference Citation Analysis]
187 Štambuk N, Konjevoda P, Pavan J. Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research. Int J Mol Sci 2021;22:9106. [PMID: 34502016 DOI: 10.3390/ijms22179106] [Reference Citation Analysis]
188 Tallei TE, Fatimawali, Yelnetty A, Idroes R, Kusumawaty D, Emran TB, Yesiloglu TZ, Sippl W, Mahmud S, Alqahtani T, Alqahtani AM, Asiri S, Rahmatullah M, Jahan R, Khan MA, Celik I. An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants. Front Pharmacol 2021;12:717757. [PMID: 34489706 DOI: 10.3389/fphar.2021.717757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Aydin F, Turkoglu V, Bas Z. Purification and characterization of angiotensin-converting enzyme (ACE) from sheep lung. Mol Biol Rep 2021;48:4191-9. [PMID: 34086160 DOI: 10.1007/s11033-021-06432-8] [Reference Citation Analysis]
190 Sayit AT, Elmali M, Deveci A, Gedikli O. Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia. Rev Inst Med Trop Sao Paulo 2021;63:e51. [PMID: 34190953 DOI: 10.1590/S1678-9946202163051] [Reference Citation Analysis]
191 Puri A, He L, Giri M, Wu C, Zhao Q. Comparison of comorbidities among severe and non-severe COVID-19 patients in Asian versus non-Asian populations: A systematic review and meta-analysis. Nurs Open 2021. [PMID: 34761532 DOI: 10.1002/nop2.1126] [Reference Citation Analysis]
192 Chakraborty C, Bhattacharya M, Mallick B, Sharma AR, Lee SS, Agoramoorthy G. SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol 2021;14:225-38. [PMID: 33423554 DOI: 10.1080/17512433.2021.1874348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
193 Queirós-Reis L, Gomes da Silva P, Gonçalves J, Brancale A, Bassetto M, Mesquita JR. SARS-CoV-2 Virus-Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response. Int J Mol Sci 2021;22:10836. [PMID: 34639178 DOI: 10.3390/ijms221910836] [Reference Citation Analysis]
194 Shoily SS, Ahsan T, Fatema K, Sajib AA. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants. Infect Genet Evol 2021;92:104888. [PMID: 33933634 DOI: 10.1016/j.meegid.2021.104888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
195 Al Armashi AR, Somoza-Cano FJ, Patell K, Homeida M, Desai O, Zubaidi AA, Altaqi B, Ravakhah K. Spontaneous pneumomediastinum: A collaborative sequelae between COVID-19 and self-inflicted lung injury - A case report and literature review. Radiol Case Rep 2021;16:3655-8. [PMID: 34630794 DOI: 10.1016/j.radcr.2021.08.076] [Reference Citation Analysis]
196 Flores-Félix JD, Gonçalves AC, Alves G, Silva LR. Consumption of Phenolic-Rich Food and Dietary Supplements as a Key Tool in SARS-CoV-19 Infection. Foods 2021;10:2084. [PMID: 34574194 DOI: 10.3390/foods10092084] [Reference Citation Analysis]
197 Hoang T. An approach of fatty acids and resveratrol in the prevention of COVID-19 severity. Phytother Res 2020. [PMID: 33200839 DOI: 10.1002/ptr.6956] [Reference Citation Analysis]
198 Mathew HR, Choi MY, Parkins MD, Fritzler MJ. Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic. BMC Pulm Med 2021;21:173. [PMID: 34016096 DOI: 10.1186/s12890-021-01528-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 2021;12:192. [PMID: 33736695 DOI: 10.1186/s13287-021-02265-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
200 Shah KS, Hale Hammond ME, Drakos SG, Anderson JL, Fang JC, Knowlton KU, Shaw RM. SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges. Future Cardiol 2021. [PMID: 33739142 DOI: 10.2217/fca-2020-0188] [Reference Citation Analysis]
201 Gupta A, Gupta GS. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs. Mol Cell Biochem 2021;476:2917-42. [PMID: 33745077 DOI: 10.1007/s11010-021-04107-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
202 Malinowska B, Baranowska-Kuczko M, Kicman A, Schlicker E. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int J Mol Sci 2021;22:1986. [PMID: 33671463 DOI: 10.3390/ijms22041986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
203 Gupta AK, Nethan ST, Mehrotra R. Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respir Med 2021;176:106233. [PMID: 33253975 DOI: 10.1016/j.rmed.2020.106233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
204 Sahu T, Mehta A, Ratre YK, Jaiswal A, Vishvakarma NK, Bhaskar LVKS, Verma HK. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. World J Gastroenterol 2021; 27(6): 449-469 [PMID: 33642821 DOI: 10.3748/wjg.v27.i6.449] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
205 Ma LL, Liu HM, Liu XM, Yuan XY, Xu C, Wang F, Lin JZ, Xu RC, Zhang DK. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19. Eur J Med Chem 2021;226:113857. [PMID: 34628234 DOI: 10.1016/j.ejmech.2021.113857] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
206 Zhu Z, Wang M, Lin W, Cai Q, Zhang L, Chen D, Liu F, Xiong X, Chu J, Peng J, Chen K. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Immun Inflamm Dis 2021. [PMID: 34405950 DOI: 10.1002/iid3.471] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]